Arizona Heart Institute

Comparative effects of glucagon-like peptide-1-based regimens on peripheral arterial and limb events in type 2 diabetes: a network meta-analysis of randomized trials

Peripheral artery disease (PAD) is a disabling condition in patients with type 2 diabetes mellitus (T2DM), yet lower-extremity outcomes are rarely prespecified in trials of GLP-1-based therapies. We compared individual GLP-1-based regimens for PAD-related vascular and limb events...